Blackcrane Capital, LLC
Follow13F filer, CIK 1720745, BELLEVUE, WA
Blackcrane Capital, LLC reported $88,401,000 across 9 holdings for the quarter ended 2020-06-30, in a 13F-HR filed 2020-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001720745-20-000004
- Period
- 2020-06-30
- Reported value
- $88.4M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 2
- Sold out
- 2
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RCELnew | +921,663 | $28.1M |
| ONCOCYTE CORPnew | +2,982,557 | $5.7M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| AVITA MEDICAL LTDexited | -5,166,338 | -$32M |
| WIXreduced | -107,295 | -$27.5M |
| MSFTreduced | -67,922 | -$13.8M |
| AXONICS INCreduced | -321,980 | -$11.3M |
| BIOHAVEN PHARMACEUTICAL HOL…reduced | -145,003 | -$10.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2020
Share positions as resolved from 13F-HR 0001720745-20-000004, largest first. % of portfolio is the value over $88,401,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| RCELAVITA MEDICAL INC | 921,663 | $28.1M | 31.84% | new | Timeline | ||
| WIXWIX COM LTD | 62,379 | $16M | 18.08% | -107,295 | Timeline | ||
| AXONICS INCAXONICS INC | 428,359 | $15M | 17.01% | -321,980 | |||
| BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDIN | 122,865 | $8.98M | 10.16% | -145,003 | |||
| NICENICE LTD | 43,657 | $8.26M | 9.35% | -23,194 | Timeline | ||
| ONCOCYTE CORPONCOCYTE CORP | 2,982,557 | $5.7M | 6.44% | new | |||
| PROFPROFOUND MED CORP | 175,301 | $2.97M | 3.36% | -47,246 | Timeline | ||
| MSFTMICROSOFT CORP | 14,039 | $2.86M | 3.23% | -67,922 | Timeline | ||
| TAKTAKEDA PHARMACEUTICAL CO LTD | 25,723 | $461K | 0.52% | -109,734 | Timeline |
Sold out in Q2 2020
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| AVITA MEDICAL LTDAVITA MEDICAL LTD | 5,166,338 | $32M | shares |
| VVISA INC | 33,024 | $5.32M | shares |
How Q2 2020 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001720745-20-000004 | base | 2020-08-14 | acceptance time not in the bulk data set |